Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer

British Journal of Cancer

Volumn 92, Issue 9, 2005, Pages 1767-1772

  Songun, I ^a   Litvinov, S V ^a   Van De Velde, C J H ^a   Pals, S T ^b   Hermans, J ^a   Van Krieken, J H J M ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

CD44; Ep CAM; Gastric cancer; Immunohistochemistry; Prognostic factor survival

Indexed keywords

CD44V ANTIGEN; EPITHELIAL CELL ADHESION MOLECULE; PROTEIN P53; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STOMACH ADENOCARCINOMA; STOMACH CANCER;

ADENOCARCINOMA; ADULT; AGED; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 19944420418     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602519     Document Type: Article

References (32)

1. Akoh JA, Sedgwick DM, Macintyre IMC (1991) Improving results in the treatment of gastric cancer: an 11-year audit. Br J Surg 78: 349-351
2. Allum WH, Powell DJ, McConkey CC, Fielding JWL (1989) Gastric Cancer: a 25-year review. Br J Surg 76: 535-540
3. Basak S, Speicher D, Eck S, Wunner W, Maul G, Simmons MS, Herlyn D (1998) Colorectal carcinoma invasion inhibition by C017-1A/GA733 antigen and its murine homologue. J Natl Cancer Inst 90: 691-697
4. Bonenkamp JJ, Hermans J, Sasako M, van deVelde CJH (1999) Extended lymph node dissection for gastric cancer. N Engl J Med 340: 908-914
5. Bonenkamp JJ, Songun I, Hermans J, Welvaart K, van de Velde CJH, Sasako M, Plukker JTM, van Elk P, Obertop H, Gouma DJ, Taat CW, van Lanschot J, Meyer S, de Graaf PW, von Meyenfeld MF, Tilanus H (1995) Randomized comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345: 745-748
6. Falck VG, Gullick WJ (1989) c-erbB-2 oncogene product staining in gastric adenocarcinoma. An immunohistochemical study. J Pathol 159: 107-111
7. Günthert BF, Liao H-X, Patton KL (1991) The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells 3: 347-350
8. Günthert U, Hoffmann M, Rudy W, Reber S, Zoller M, Haussman I, Matzku S, Wenzel A, Ponta H, Herrlich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13-24
9. Günthert U, Stauder R, Mayer B, Terpe HJ, Finke L, Friedrichs K (1995) Are CD44 variants isoforms involved in human tumour progression? Cancer Surv 24: 19-24
10. Haynes BF, Telen MJ, Hale LP, Denning SM (1989) CD44 - a molecule involved in leukocyte adherence and T-cell activation. Immunol Today 10: 423-428
11. Heider K-H, Dämmrich J, Skroch-Angel P, Muller-Hermelinck HK, Vollmers HP, Herrlich P, Ponta H (1993) Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 53: 4197-4203
12. Hermanek P, Marnyama K, Sobin LH (1985) Prognostic factors in stomach cancer. In: Hermanek P, Gospodarowicz MK, Henson DE, Hutter RVP, Sobin LH (eds) Prognostic factor in cancer. Berlin: Springer, Verlag
13. Hermans J, Bonenkamp JJ, Boon MC, Bunt AMG, Lhyama S, Sasako M, van de Velde CJH (1999) Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. Classic Paper Curr Comments 3:281-288
14. Houldsworth J, Cordon-Cardo C, Ladanyi M, Kelsen DP, Chaganti RS (1990) Gene amplification in gastric and esophageal adenocarcinoma. Cancer Res 50: 6417-6422
15. Koopman G, Heider KH, Horst E, Adolf GR, van den Berg F, Ponta H, Herrlich P, Pals ST (1993) Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 177: 897-904
16. Litvinov SV (1995) Ep-CAM: a homophilic cell-cell adhesion molecule with EGF-like domains. Trends Glycosci Glycotechnol 7: 375-384
17. Litvinov SV, Bakker HAM, Gourevitch MM, Velders MP, Warnaar SO (1994b) Evidence for a role of the epithelial glycorotein 40 (Ep-CAM) in epithelial cell-cell adhesion. Cell Adhesion Commun 2: 417-428
18. Litvinov SV, Velders MP, Bakker HAM, Fleuren GJ, Warnaar SO (1994a) Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J Cell Biol 125: 437-446
19. Mayer B, Jauch KW, Günthert U, Figdor CG, Schildberg FW, Funke I, Johnson JP (1993) De-novo expression of CD44 and survival in gastric cancer. Lancet 342: 1019-1022
20. Mirecka J, Marx D, Schauer A (1995) Immunohistochemical localization of CD44 variants 5 and 6 in human gastric mucosa and gastric cancer. Anticancer Res 15: 1459-1465
21. Miwa K, Japanese Research Society for Gastric Cancer (1984) Evaluation of the TNM classification of stomach cancer and proposal for its rational stage grouping. Jpn J Clin Oncol 14: 385-410
22. Mulder JWR, Kruyt PM, Sewnath M, Costing J, Seldenrijk CA, Weidema WF, Offerhaus GJ, Pals ST (1994) Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 344: 1470-1472
23. Muller W, Schneiders A, Heider KH, Meier S, Hommel G, Gabbert HE (1997) Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer. J Pathol 183: 222-227
24. Salmi M, Grön-Virta K, Sointu P, Grenman R, Kalimo H, Jalkanen S (1993) Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol 122: 431-442
25. Songun I, van de Velde CJ, Hermans J, Pals ST, Verspaget HW, Vis AN, Menon AG, Litvinov SV, van Krieken JH (1996) Expression of oncoproteins and the amount of eosinophilic and lymphocytic infiltrates can be used as prognostic factors in gastric cancer. Br J Cancer 74(11): 1783-1788
26. Suriano G, Oliveira MJ, Huntsman D, Mateus AR, Ferreira P, Casares F, Oliveira C, Carneiro F, Machado JC, Mareel M, Seruca R (2003) E-cadherin germ line missence mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells. Hum Mol Genet 12(22): 3007-3016
27. Tandon AK, Clark GM, Chamness GC, McGuire WL (1990) Association of the 323/A3 surface glycoprotein with tumor characteristics and behavior in human breast cancer. Cancer Res 50: 3317-3321
28. Terpe H-J, Stark H, Prehm P, Günthert U (1994) CD44 variant isoforms are preferentially expressed in basal epithelia of non-malignant human fetal and adult tissues. Histochemistry 101: 79-89
29. Van der Wurff AA, ten Kate J, van der Linden EP, ten Kate J, Bosman FT (1992) L-CAM expression in normal, premalignant, and malignant mucosa. J Pathol 168(3): 287-291
30. Van der Wurff AA, Vermeulen SJ, van der Linden EP, Mareel MM, Bosman FT, Arends JW (1997) Patterns of alpha- and beta-catenin and E-cadherin expression in colorectal adenomas and carcinomas. J Pathol 182(3): 325-330
31. Wanebo HJ, Kennedy BJ, Chmiel J, Steele Jr G, Winchester D, Osteen R (1993) Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 218: 583-592
32. Yu W, Whang I, Suh I, Averbach A, Chang D, Sugarbaker PH (1998) Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg 3: 347-354